Therapeutic Dilemmas in Mixed Septic-Cardiogenic Shock.
Am J Med
; 136(1): 27-32, 2023 01.
Article
en En
| MEDLINE
| ID: mdl-36252709
Sepsis is an increasing cause of decompensation in patients with chronic heart failure with reduced or preserved ejection fraction. Sepsis and decompensated heart failure results in a mixed septic-cardiogenic shock that poses several therapeutic dilemmas: Rapid fluid resuscitation is the cornerstone of sepsis management, while loop diuretics are the main stay of decompensated heart failure treatment. Whether inotropic therapy with dobutamine or inodilators improves microvascular alterations remains unsettled in sepsis. When to resume loop diuretic therapy in patients with sepsis and decompensated heart failure is unclear. In the absence of relevant guidelines, we review vasopressor therapy, the timing and volume of fluid resuscitation, and the need for inotropic therapy in patients who, with sepsis and decompensated heart failure, present with a mixed septic-cardiogenic shock.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Choque Cardiogénico
/
Insuficiencia Cardíaca
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Am J Med
Año:
2023
Tipo del documento:
Article
Pais de publicación:
Estados Unidos